Renato D. Lópes

Also affiliated with Duke University, Clinical Research Institute, Duke Medical Center, University of Glasgow, Universidade Federal de São Paulo

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 51 papers. Top paper: “Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia”.

Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia

JAMA Cardiology(2020)10.1001/jamacardio.2020.0822

N/A

4.8DataRank · unranked

157 citations

Leslee J. Shaw, James K. Min, John A. Spertus, Bernard Chaitman, Daniel S. Berman +26 more

Survival After Invasive or Conservative Management of Stable Coronary Disease

Circulation(2022)10.1161/circulationaha.122.062714

N/A

3.4DataRank · unranked

148 citations

Rebecca Anthopolos, Harmony R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O’Brien +73 more

Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.05.002

N/A

1.8DataRank · unranked

72 citations

Christopher B. Granger, Daniel Wojdyla, William F. McIntyre, Marco Alings, Thenmozhi Mani +23 more

Ischemia With Nonobstructive Coronary Arteries

JACC. Cardiovascular imaging(2022)10.1016/j.jcmg.2022.06.015

N/A

1.7DataRank · unranked

74 citations

Ariel Díaz, Derek D. Cyr, Leslee J. Shaw, G.B. John Mancini, Jonathon Leipsic +22 more

Impact of Complete Revascularization in the ISCHEMIA Trial

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.06.015

N/A

1.6DataRank · unranked

45 citations

Ziad A. Ali, Sean M. O’Brien, Grace L. Rhodes, Philippe Généreux, Sripal Bangalore +89 more

Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction

JAMA(2022)10.1001/jama.2022.11016

N/A

1.4DataRank · unranked

62 citations

Adriaan A. Voors, Alain Cohen‐Solal, Marco Metra, David J. Whellan, Justin A. Ezekowitz +12 more

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2011)10.1056/nejmoa1107039

N/A

1.4DataRank · unranked

8849 citations

John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna +37 more

Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial

American Heart Journal(2022)10.1016/j.ahj.2022.04.001

N/A

1.1DataRank · unranked

19 citations

Pedro Gabriel Melo de Barros e Silva, Thiago Ceccatto de Paula, Renata Moll‐Bernardes, Tiago Mendonça dos Santos, Lilian Mazza +10 more

Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial

Circulation(2023)10.1161/circulationaha.122.063716

N/A

0.901DataRank · unranked

25 citations

Zhuoru Li, Chinthanie Ramasundarahettige, Seung Jae Baek, Kelley R. Branch, Stefano Del Prato +6 more

Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00362-0

N/A

0.700DataRank · unranked

31 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Silvio E. Inzucchi +17 more

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Journal of the American Heart Association(2024)10.1161/jaha.122.029850

N/A

0.654DataRank · unranked

18 citations

Derek D. Cyr, C. Noel Bairey Merz, Leslee J. Shaw, Bernard Chaitman, William E. Boden +91 more

Research Priorities in Atrial Fibrillation Screening

Circulation(2021)10.1161/circulationaha.120.047633

N/A

0.639DataRank · unranked

70 citations

Alan S. Go, Patrice Desvigne‐Nickens, Christopher D. Anderson, Barbara Casadei, Lin Y. Chen +21 more

Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial

Circulation Cardiovascular Interventions(2022)10.1161/circinterventions.122.012103

N/A

0.604DataRank · unranked

16 citations

Derek D. Cyr, Karen P. Alexander, Radosław Pracoń, Kevin R. Bainey, Anoop Mathew +12 more

Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial

Circulation(2024)10.1161/circulationaha.124.071208

N/A

0.589DataRank · unranked

21 citations

J. Dawn Abbott, Brandon M. Herbert, Marnie Bertolet, Bernard Chaitman, Harvey D. White +19 more

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas

Open Heart(2021)10.1136/openhrt-2020-001471

N/A

0.555DataRank · unranked

12 citations

Ziad Hijazi, Johan Lindbäck, John H. Alexander, M. Cecilia Bahit, Raffaele De Caterina +9 more

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials

European Heart Journal(2024)10.1093/eurheartj/ehae596

N/A

0.542DataRank · unranked

36 citations

Juan Benezet‐Mazuecos, Nina Becher, William F McIntyre, Alexander Fierenz, Shun Fu Lee +28 more

Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

American Heart Journal(2022)10.1016/j.ahj.2022.01.017

N/A

0.505DataRank · unranked

28 citations

Karen P. Alexander, Zhen Huang, Sean M. O’Brien, Bernard Chaitman, Gregg W. Stone +29 more

Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial

American Heart Journal(2020)10.1016/j.ahj.2020.10.066

N/A

0.449DataRank · unranked

19 citations

Amanda Stebbins, Vignesh Raman, Brooke Alhanti, Sean van Diepen, Matthias Heringlake +9 more

Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00218-3

N/A

0.449DataRank · unranked

13 citations

Sheryl L. Windsor, Orly Vardeny, Jeffrey S. Berger, Harmony R Reynolds, Stavroula Boumakis +75 more

Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis

American Heart Journal(2020)10.1016/j.ahj.2020.10.065

N/A

0.442DataRank · unranked

18 citations

David E. Wang, Ankeet S. Bhatt, Alexander Blood, Musa Sharkawi, Hasan K. Siddiqi +9 more

Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial

The American Journal of Medicine(2022)10.1016/j.amjmed.2022.02.016

N/A

0.401DataRank · unranked

5 citations

Patrícia O. Guimarães, Gregory G. Schwartz, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj +13 more

ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor

American Heart Journal(2022)10.1016/j.ahj.2022.04.005

N/A

0.396DataRank · unranked

13 citations

Steven J. Atlas, Alan S. Go, Renato D. Lópes, Steven A. Lubitz, David D. McManus +6 more

Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial

European Heart Journal(2025)10.1093/eurheartj/ehaf347

N/A

0.292DataRank · unranked

6 citations

Thomas A. Nelson, Justin Lee, Heather M. Judge, Ramzi Ajjan, Johan Westerbergh +9 more

Time to Clinical Benefit with Sotagliflozin in Patients with Type 2 Diabetes and Chronic Kidney Disease: Insights from the SCORED Randomized Trial

European Journal of Heart Failure(2024)10.1002/ejhf.3240

N/A

0.241DataRank · unranked

4 citations

Deepak L. Bhatt, Michael Szarek, Lawrence A. Leiter, Christopher P. Cannon, Renato D. Lópes +5 more

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial

CHEST Journal(2023)10.1016/j.chest.2023.11.019

N/A

0.216DataRank · unranked

3 citations

Kinsley Hubel, Joshua Froess, Stephen R. Wisniewski, Vidya Venugopal, Yu‐Hsuan Lai +23 more

Comparative Prognosis by Stress ECG and Stress Imaging

JACC. Cardiovascular imaging(2025)10.1016/j.jcmg.2025.03.016

N/A

0.208DataRank · unranked

3 citations

Lawrence M. Phillips, Jonathon Leipsic, Samuel Broderick, Jennifer H. Mieres, Thomas H. Marwick +18 more

International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Circulation Cardiovascular Quality and Outcomes(2024)10.1161/circoutcomes.123.010534

N/A

0.208DataRank · unranked

3 citations

John A. Spertus, Dan Nguyen, Zhuxuan Fu, Philip G. Jones, Harmony R. Reynolds +18 more

Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial

Diabetes Care(2025)10.2337/dc24-2629

N/A

0DataRank · unranked

0 citations

Carolyn S.P. Lam, Shofiqul Islam, Stefano Del Prato, Renato D. Lópes, Richard E. Pratley +4 more

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

American Heart Journal(2020)10.1016/j.ahj.2020.05.002

N/A

0DataRank · unranked

144 citations

Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Renata Moll‐Bernardes, André Feldman, Guilherme Arruda +10 more

Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials

American Heart Journal(2020)10.1016/j.ahj.2020.10.064

N/A

0DataRank · unranked

113 citations

Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al‐Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta +6 more

Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve

American Heart Journal(2020)10.1016/j.ahj.2020.06.014

N/A

0DataRank · unranked

82 citations

Tracy Y. Wang, Renato D. Lópes, Alma Chavez, Brittanny Boyer, Hwasoon Kim +12 more

Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update

American Heart Journal(2020)10.1016/j.ahj.2020.12.007

N/A

0DataRank · unranked

52 citations

Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al‐Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta +6 more

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

American Heart Journal(2020)10.1016/j.ahj.2020.12.002

N/A

0DataRank · unranked

32 citations

Hwanhee Hong, Robert P. Giugliano, Stuart J. Connolly, John W. Eikelboom, Manesh R. Patel +12 more

Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial

American Heart Journal(2020)10.1016/j.ahj.2020.08.001

N/A

0DataRank · unranked

12 citations

Morgan L. Cox, David N. Ranney, Judson B. Williams, Hillary Mulder, Mario Gaudino +7 more

Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018

American Heart Journal(2021)10.1016/j.ahj.2021.12.012

N/A

0DataRank · unranked

8 citations

Kenneth W. Mahaffey, C. Michael Gibson, Karen A. Hicks, Karen P. Alexander, Maria Ali +12 more

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial

Journal of the American Heart Association(2021)10.1161/jaha.121.023143

N/A

0DataRank · unranked

1 citations

Daniel M. Wojdyla, John H. Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker +7 more

Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention – Insights from the CHAMPION program

American Heart Journal Plus Cardiology Research and Practice(2021)10.1016/j.ahjo.2021.100043

N/A

0DataRank · unranked

0 citations

Robert A. Harrington, Gregg W. Stone, Philippe Gabríel Steg, C. Michael Gibson, Christian W. Hamm +9 more

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

Cardiovascular Diabetology(2022)10.1186/s12933-022-01455-2

N/A

0DataRank · unranked

85 citations

Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al‐Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta +6 more

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.48030

N/A

0DataRank · unranked

74 citations

Emily C. O’Brien, Lisa A. Kaltenbach, Jennifer B. Green, Renato D. Lópes, Caryn G. Morse +16 more

Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model

American Heart Journal(2022)10.1016/j.ahj.2022.03.009

N/A

0DataRank · unranked

23 citations

Ziad Hijazi, Johan Lindbäck, John H. Alexander, Bernard J. Gersh, Christopher B. Granger +8 more

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Circulation(2023)10.1161/circulationaha.123.064473

N/A

0DataRank · unranked

173 citations

Roxana Mehran, Mitchell W. Krucoff, Usman Baber, Deepak L. Bhatt, Piera Capranzano +36 more

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

JACC Heart Failure(2023)10.1016/j.jchf.2023.05.026

N/A

0DataRank · unranked

46 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire +17 more

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.14428

N/A

0DataRank · unranked

17 citations

Matthew D. Neal, Lucy Z. Kornblith, Michelle N. Gong, Harmony R. Reynolds, Mary Cushman +72 more

Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta-analyses in dialysis and non-dialysis dependent populations

Clinical Kidney Journal(2023)10.1093/ckj/sfad298

N/A

0DataRank · unranked

15 citations

Renato D. Lópes, Csaba P. Kövesdy, Aleix Cases, Steve A Mallett, Nick Ballew +8 more

Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop

Stroke(2023)10.1161/strokeaha.121.038273

N/A

0DataRank · unranked

6 citations

Sana M. Al‐Khatib, Patrice Desvigne‐Nickens, Nisha Bansal, Cheryl Bushnell, Margaret C. Fang +15 more

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

European Heart Journal(2024)10.1093/eurheartj/ehae614

N/A

0DataRank · unranked

26 citations

Danielle Duffy, M. Cecilia Bahit, Gerald Chi, Harvey D. White, Serge Korjian +71 more

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.03.396

N/A

0DataRank · unranked

30 citations

Serge Korjian, M. Cecilia Bahit, Gerald Chi, Danielle Duffy, John H. Alexander +34 more

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae006

N/A

0DataRank · unranked

15 citations

Guillaume Marquis‐Gravel, Shannon Murphy, Karen P. Alexander, Karen Chiswell, Jennifer B. Green +8 more

Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Journal of the American Heart Association(2024)10.1161/jaha.123.033720

N/A

0DataRank · unranked

13 citations

Johan Lindbäck, John H. Alexander, Christopher B. Granger, Peter Kastner, Renato D. Lópes +6 more

The metabolic syndrome and risk of sudden cardiac death: The atherosclerosis risk in communities study

UNC Libraries(2024)10.17615/yds3-yc29

N/A

0DataRank · unranked

0 citations

Nona Sotoodehnia, R. J. Prineas, W.R Rosamond, W. S. Post, D.B Mark +9 more

Empagliflozin After Myocardial Infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

ESC Heart Failure(2025)10.1002/ehf2.15393

N/A

0DataRank · unranked

1 citations

Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington +19 more